Himalaya Nutradetics India Limited is a Hyderabad-based manufacturer of Ayurvedic and nutraceutical formulations that sells its own condition-focused products and also produces for third-party brands. The company operates a single integrated, WHO-GMP/AYUSH/FSSAI-compliant facility capable of making multiple dosage forms (softgels, tablets, hard capsules, liquid orals and medicated oils) and markets largely through a prescription-adjacent model driven by medical representatives, pharmacies, stockists and super-stockists across multiple Indian states.
Overall Subscribed
Open Date
22 Sept 2026
Close Date
24 Sept 2026
Allotment
TBA
Listing
29 Sept 2026
| Fiscal Period | Revenue (Cr) | Net Profit (Cr) | Total Assets (Cr) |
|---|---|---|---|
Institutional Data Pending Aggregating historical filings... | |||
Total Issue Size
₹26.5 Cr
Fresh Issue
₹0 Cr
OFS Size
₹0 Cr
Price Performance Band
₹100 — ₹106
Detailed allocation objectives are currently being processed by the intelligence engine.
A curated synthesis of common investor inquiries and institutional data points for Himalaya Nutravedics I....
Himalaya Nutradetics India Limited is a Hyderabad-based manufacturer of Ayurvedic and nutraceutical formulations that sells its own condition-focused products and also produces for third-party brands. The company operates a single integrated, WHO-GMP/AYUSH/FSSAI-compliant facility capable of making multiple dosage forms (softgels, tablets, hard capsules, liquid orals and medicated oils) and markets largely through a prescription-adjacent model driven by medical representatives, pharmacies, stockists and super-stockists across multiple Indian states.
The company plans to utilize the fresh issue proceeds for general corporate purposes and working capital requirements as outlined in the RHP.
A retail investor can apply for a minimum of 1 lot (1200 shares) at the price band of ₹100 - ₹106.
The lead managers are listed in the detailed RHP document, reachable via the terminal's stakeholder section above.